Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Laufer

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Family Practice|October 25, 2001
Pneumonia vaccineF J Malinoski, D S Laufer
Pediatric Clinics of North America|June 1, 1995
Resistance to antiviralsD S Laufer, S E Starr
International Journal of Clinical Practice|April 20, 2006
Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?M A Fletcher, D S Laufer, E D G McIntosh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995
Saliva and serum as diagnostic media for antibody to hepatitis A virus in adults and in individuals who have received an inactivated hepatitis A vaccineD S Laufer, W Hurni, B Watson, et al.
The Journal of Infectious Diseases|March 1, 1996
Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy childrenB M Watson, D S Laufer, B J Kuter, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Family Practice|October 25, 2001
Pneumonia vaccineF J Malinoski, D S Laufer
Pediatric Clinics of North America|June 1, 1995
Resistance to antiviralsD S Laufer, S E Starr
International Journal of Clinical Practice|April 20, 2006
Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?M A Fletcher, D S Laufer, E D G McIntosh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995
Saliva and serum as diagnostic media for antibody to hepatitis A virus in adults and in individuals who have received an inactivated hepatitis A vaccineD S Laufer, W Hurni, B Watson, et al.
The Journal of Infectious Diseases|March 1, 1996
Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy childrenB M Watson, D S Laufer, B J Kuter, et al.
Pageof 1